Corporate Investor Profile
In the last 3 years, Novo Holdings A/S has acquired 11 companies. It has also invested in 1 other.
Novo Holdings A/S’s most common sectors for investment arelife science (44%) and medical products (13%) . The Firm’s most common investment types include secondary buyout (50%) and divestiture (13%). In total, Novo Holdings A/S has invested in 6 US states and 6 different countries. Its largest (disclosed) acquisition occurred in 2024 when it acquired Catalent for $16.5B.
In the last 3 years, Novo Holdings A/S has exited 1 company. The Firm’s most common exit type is secondary buyout (100%). Novo Holdings A/S’s largest (disclosed) exit occurred in 2021 when it sold Unchained Labs for $435M.
Join Mergr to view Novo Holdings A/S’s full profile and discover more middle-market corporate investor investors just like it.
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity16
- M&A Sell Activity1
- Total Sectors Invested 8
- Total Countries Invested 6
- M&A Buy/Sell Connections 5
- M&A Advisors 14